Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 51406

1.

Extracellular matrix protein tenascin C increases phagocytosis mediated by CD47 loss of function in glioblastoma.

Xia S, Ma D, Liu S, Lal B, Wei S, Wang S, Zhan D, Zhang H, Lee RS, Gao P, Lopez-Bertoni H, Ying M, Li JJ, Laterra J, Wilson MA.

Cancer Res. 2019 Mar 21. pii: canres.3125.2018. doi: 10.1158/0008-5472.CAN-18-3125. [Epub ahead of print]

PMID:
30898840
2.

Epigenomic reordering induced by Polycomb loss drives oncogenesis but leads to therapeutic vulnerabilities in malignant peripheral nerve sheath tumors.

Wojcik JB, Marchione DM, Sidoli S, Djedid A, Lisby A, Majewski J, Garcia BA.

Cancer Res. 2019 Mar 21. pii: canres.3704.2018. doi: 10.1158/0008-5472.CAN-18-3704. [Epub ahead of print]

PMID:
30898839
3.

Genome-wide interrogation of human cancers identifies EGLN1 dependency in clear cell ovarian cancers.

Price C, Gill S, Ho ZV, Davidson SM, Merkel E, McFarland JM, Leung L, Tang A, Kost-Alimova M, Tsherniak A, Jonas O, Vazquez F, Hahn WC.

Cancer Res. 2019 Mar 21. pii: canres.2674.2018. doi: 10.1158/0008-5472.CAN-18-2674. [Epub ahead of print]

PMID:
30898838
4.

Susceptibility perturbation MRI (SPI) maps tumor infiltration into mesorectal lymph nodes.

Santiago I, Santinha J, Ianus A, Galzerano A, Theias R, Maia J, Barata MJ, Loução N, Costa-Silva B, Beltran A, Matos C, Shemesh N.

Cancer Res. 2019 Mar 20. pii: canres.3682.2018. doi: 10.1158/0008-5472.CAN-18-3682. [Epub ahead of print]

PMID:
30894376
5.

The Critical Role of RNA m6A Methylation in Cancer.

Lan Q, Liu PY, Haase J, Bell JL, Hüttelmaier S, Liu T.

Cancer Res. 2019 Mar 20. doi: 10.1158/0008-5472.CAN-18-2965. [Epub ahead of print] Review.

PMID:
30894375
6.

Citrullination in Cancer.

Yuzhalin AE.

Cancer Res. 2019 Mar 20. doi: 10.1158/0008-5472.CAN-18-2797. [Epub ahead of print] Review.

PMID:
30894374
7.

An Interactive Resource to Probe Genetic Diversity and Estimated Ancestry in Cancer Cell Lines.

Dutil J, Chen Z, Monteiro AN, Teer JK, Eschrich SA.

Cancer Res. 2019 Mar 20. doi: 10.1158/0008-5472.CAN-18-2747. [Epub ahead of print] Review.

PMID:
30894373
8.

4E-BP1 Is a Tumor Suppressor Protein Reactivated by mTOR Inhibition in Head and Neck Cancer.

Wang Z, Feng X, Molinolo AA, Martin D, Vitale-Cross L, Nohata N, Ando M, Wahba A, Amornphimoltham P, Wu X, Gilardi M, Allevato M, Wu V, Steffen DJ, Tofilon P, Sonenberg N, Califano J, Chen Q, Lippman SM, Gutkind JS.

Cancer Res. 2019 Mar 20. doi: 10.1158/0008-5472.CAN-18-1220. [Epub ahead of print]

PMID:
30894372
9.

Negative regulation of p53-induced senescence by N-WASP is crucial for DMBA/TPA-induced skin tumor formation.

Li H, Petersen S, Garcia Mariscal A, Brakebusch C.

Cancer Res. 2019 Mar 20. pii: canres.1253.2018. doi: 10.1158/0008-5472.CAN-18-1253. [Epub ahead of print]

PMID:
30894371
10.

Inhibition of miR-328-3p impairs cancer stem cell function and prevents metastasis in ovarian cancer.

Srivastava AK, Banerjee A, Cui T, Han C, Cai S, Liu L, Wu D, Cui R, Li Z, Zhang X, Xie G, Selvendiran K, Patnaik S, Karpf AR, Liu J, Cohn DE, Wang QE.

Cancer Res. 2019 Mar 20. pii: canres.3668.2018. doi: 10.1158/0008-5472.CAN-18-3668. [Epub ahead of print]

PMID:
30894370
11.

Inhibition of EphB4-ephrin-B2 signaling reprograms the tumor immune microenvironment in head and neck cancers.

Bhatia S, Oweida A, Lennon S, Darragh LB, Milner D, Phan AV, Mueller AC, Van Court B, Raben D, Serkova NJ, Wang XJ, Jimeno A, Clambey ET, Pasquale EB, Karam SD.

Cancer Res. 2019 Mar 20. pii: canres.3257.2018. doi: 10.1158/0008-5472.CAN-18-3257. [Epub ahead of print]

PMID:
30894369
12.

Picosecond infrared laser desorption mass spectrometry identifies medulloblastoma subgroups on intrasurgical timescales.

Woolman M, Kuzan-Fischer CM, Ferry I, Kiyota T, Luu B, Wu M, Munoz DG, Das S, Aman A, Taylor MD, Rutka JT, Ginsberg HJ, Zarrine-Afsar A.

Cancer Res. 2019 Mar 19. pii: canres.3411.2018. doi: 10.1158/0008-5472.CAN-18-3411. [Epub ahead of print]

PMID:
30890619
13.

CD317 activates EGFR by regulating its association with lipid rafts.

Zhang G, Li X, Chen Q, Li J, Ruan Q, Chen YH, Yang X, Wan X.

Cancer Res. 2019 Mar 19. pii: canres.2603.2018. doi: 10.1158/0008-5472.CAN-18-2603. [Epub ahead of print]

PMID:
30890618
14.

Myc and loss of p53 cooperate to drive formation of choroid plexus carcinoma.

Wang J, Merino DM, Light N, Murphy BL, Wang YD, Guo X, Hodges AP, Chau LQ, Liu KW, Dhall G, Asgharzadeh S, Kiehna EN, Shirey RJ, Janda KD, Taylor MD, Malkin D, Ellison DW, VandenBerg SR, Eberhart CG, Sears RC, Roussel MF, Gilbertson RJ, Wechsler-Reya RJ.

Cancer Res. 2019 Mar 18. pii: canres.2565.2018. doi: 10.1158/0008-5472.CAN-18-2565. [Epub ahead of print]

PMID:
30885981
15.

PDLIM2 is a marker of adhesion and β-catenin activity in triple-negative breast cancer.

Cox OT, Edmunds SJ, Simon-Keller K, Li B, Moran B, Buckley NE, Bustamante-Garrido M, Healy N, O'Flanagan CH, Gallagher WM, Kennedy RD, Bernards R, Caldas C, Chin SF, Marx A, O'Connor R.

Cancer Res. 2019 Mar 18. pii: canres.2787.2018. doi: 10.1158/0008-5472.CAN-18-2787. [Epub ahead of print]

PMID:
30885980
16.

Inhibition of NF-κB-dependent signaling enhances sensitivity and overcomes resistance to BET inhibition in uveal melanoma.

Ambrosini G, Do C, Tycko B, Realubit RB, Karan C, Musi E, Carvajal RD, Chua V, Aplin AE, Schwartz GK.

Cancer Res. 2019 Mar 18. pii: canres.3177.2018. doi: 10.1158/0008-5472.CAN-18-3177. [Epub ahead of print]

PMID:
30885979
17.

An HK2 antisense oligonucleotide induces synthetic lethality in HK1-HK2+ multiple myeloma.

Xu S, Zhou T, Doh HM, Trinh KR, Catapang A, Lee JT, Braas D, Bayley NA, Yamada RE, Vasuthasawat A, Sasine JP, Timmerman JM, Larson SM, Kim Y, Macleod AR, Morrison SL, Herschman HR.

Cancer Res. 2019 Mar 18. pii: canres.2799.2018. doi: 10.1158/0008-5472.CAN-18-2799. [Epub ahead of print]

PMID:
30885978
18.

Regulation of miRNA biogenesis and histone modification by K63-polyubiquitinated DDX17 controls cancer stem-like features.

Kao SH, Cheng WC, Wang YT, Wu HT, Yeh HY, Chen YJ, Tsai MH, Wu KJ.

Cancer Res. 2019 Mar 15. pii: canres.2376.2018. doi: 10.1158/0008-5472.CAN-18-2376. [Epub ahead of print]

PMID:
30877109
19.

Pan-TAM tyrosine kinase inhibitor BMS-777607 enhances anti-PD-1 mAb efficacy in a murine model of triple-negative breast cancer.

Kasikara C, Davra V, Calianese D, Geng K, Spires TE, Quigley M, Wichroski M, Sriram G, Suarez-Lopez L, Yaffe MB, Kotenko SV, De Lorenzo MS, Birge RB.

Cancer Res. 2019 Mar 15. pii: canres.2614.2018. doi: 10.1158/0008-5472.CAN-18-2614. [Epub ahead of print]

PMID:
30877108
20.

MRI Imaging of the Hemodynamic Vasculature of Neuroblastoma Predicts Response to Anti-angiogenic Treatment.

Zormpas-Petridis K, Jerome NP, Blackledge MD, Carceller F, Poon E, Clarke M, McErlean CM, Barone G, Koers A, Vaidya SJ, Marshall LV, Pearson ADJ, Moreno L, Anderson J, Sebire N, McHugh K, Koh DM, Yuan Y, Chesler L, Robinson SP, Jamin Y.

Cancer Res. 2019 Mar 15. pii: canres.3412.2018. doi: 10.1158/0008-5472.CAN-18-3412. [Epub ahead of print]

PMID:
30877107

Supplemental Content

Loading ...
Support Center